HomeInsights52 Week Low Stocks

Glenmark Pharmaceuticals Ltd 52 Week Low

Glenmark Pharmaceuticals Ltd 52 Week Low

stocks purchased

₹ 0.7 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

5.0 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 23, 2024

Image

Glenmark Pharmaceuticals Ltd

NSE: GLENMARK

YEARLOW

₹ 761.15

Last updated on: Nov 22, 2024

Key Highlights

  • The 52 Week Low of Glenmark Pharmaceuticals Ltd is ₹ 761.15 as of 22 Nov 24 .

Company Fundamentals for Glenmark Pharmaceuticals Ltd

No data available

Market Price of Glenmark Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Glenmark Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 20241480.05
21 Nov 20241465.3
19 Nov 20241492.35
18 Nov 20241483.5
14 Nov 20241531.7
13 Nov 20241538.5
12 Nov 20241577.25
11 Nov 20241634.7
08 Nov 20241665.5
07 Nov 20241657.7

Asset Value vs Market Value of Glenmark Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Glenmark Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Glenmark Pharmaceuticals Ltd

No data available

* All values are in crore

Glenmark Pharmaceuticals Ltd News Hub

News

Glenmark Pharmaceuticals Ltd eases for fifth straight session

Glenmark Pharmaceuticals Ltd dropped for a fifth straight session today. The stock is quot...

Read more

18 Nov 202413:35

News

Glenmark Pharma reports turnaround Q2 results

Revenue from operations increased 2.29% year on year (YoY) to Rs 3,133.79 crore in the qua...

Read more

15 Nov 202414:40

News

Glenmark Pharmaceuticals Ltd gains for third straight session

Glenmark Pharmaceuticals Ltd gained for a third straight session today. The stock is quoti...

Read more

06 Nov 202413:05

News

Glenmark Pharmaceuticals declare Quarterly Result

Glenmark Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 1...

Read more

31 Oct 202412:07

News

Glenmark Pharmaceuticals Ltd spurts 2.21%

Glenmark Pharmaceuticals Ltd is up for a third straight session today. The stock is quotin...

Read more

08 Oct 202413:05

News

Glenmark Pharma spurts as Maharashtra facility clears USFDA inspection

The inspection was conducted from 9 September to 20 September 2024. In conclusion, the US ...

Read more

23 Sep 202410:12

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week Low of Glenmark Pharmaceuticals Ltd

Why is it important to track the 52-week low of Glenmark Pharmaceuticals Ltd stocks?

Investors should monitor the 52-week low of Glenmark Pharmaceuticals Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time. Frequent monitoring will help traders identify trends and make timely decisions.

What factors can lead to Glenmark Pharmaceuticals Ltd stocks hitting a 52-week low?

Factors leading to Glenmark Pharmaceuticals Ltd stocks hitting a 52-week low may include poor fiscal results, negative industry trends, macroeconomic issues, or management changes. Other factors such as market volatility and broader economic downturns can also contribute to a 52-week low.

Should investors buy Glenmark Pharmaceuticals Ltd stocks when they hit a 52-week low?

Buying Glenmark Pharmaceuticals Ltd stocks at a 52-week low can offer a potential bargain, however, it is crucial to evaluate the reasons behind the stock price drop and ensure there is no underlying fundamental issue. Investors should consider the company's long-term prospects before making a buying decision.

How often should investors monitor the 52-week low of Glenmark Pharmaceuticals Ltd stocks?

Investors should monitor the 52-week low of Glenmark Pharmaceuticals Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time, which will help them identify trends and make timely decisions.

How can an investor assess the risk of buying Glenmark Pharmaceuticals Ltd stock at their 52-week low?

An investor can analyze the reasons for the Glenmark Pharmaceuticals Ltd stock price drop, evaluate the company’s fundamentals, and consider market conditions. Investors should also review the stock’s historical performance and any potential recovery indicators.

Should investors consider the overall market trend when evaluating Glenmark Pharmaceuticals Ltd stocks at their 52-week low?

Certainly, considering the overall market trend when evaluating Glenmark Pharmaceuticals Ltd stocks at their 52-week low is significant as it provides context for the stock’s performance and potential future movements. A declining market trend may influence Glenmark Pharmaceuticals Ltd stock performance, impacting the timing and potential of the investment.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*